Prognostic Role of Cell Cycle and Proliferative Markers in Clear Cell Renal Cell Carcinoma
Authors:
- 1 February 2016
- journal article
- research article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 43 (1) , 105-118
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Differential Expression of Prognostic Proteomic Markers in Primary Tumour, Venous Tumour Thrombus and Metastatic Renal Cell Cancer Tissue and Correlation with Patient OutcomePLOS ONE, 2013
- High cytoplasmic expression of p27 Kip1 is associated with a worse cancer‐specific survival in clear cell renal cell carcinomaBJU International, 2011
- Immunoexpression Status and Prognostic Value of mTOR and Hypoxia-Induced Pathway Members in Primary and Metastatic Clear Cell Renal Cell CarcinomasAmerican Journal of Surgical Pathology, 2011
- Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinomaUrologic Oncology: Seminars and Original Investigations, 2011
- Small Renal MassNew England Journal of Medicine, 2010
- Development and evaluation of BioScoreCancer, 2009
- Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray studyJournal of Experimental & Clinical Cancer Research, 2008
- Impact of mutant p53 functional properties onTP53mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 databaseHuman Mutation, 2007
- Prognostic value of the expression of Ki‐67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinomaBJU International, 2004
- Assessing TP53 status in human tumours to evaluate clinical outcomeNature Reviews Cancer, 2001